Senescent Periodontal Ligament Stem Cells as Drivers of Myeloid-Derived Suppressor Cell Recruitment in Periodontitis-Associated Oral Squamous Cell Carcinoma

OSCC remains one of the most common oral malignancies and continues to be associated with high morbidity and mortality. Several studies suggests that chronic periodontitis contributes to oral carcinogenesis by creating an inflammatory and immunosuppressive microenvironment. Continuous microbial stimulation, oxidative stress, and inflammatory mediator release promotes tissue destruction and favour tumour initiation and progression.
PDLSCs play a central role in maintaining periodontal homeostasis and regeneration; however, a prolonged inflammatory environment induces cellular senescence, resulting in the development of SASP. Senescent PDLSCs secrete inflammatory cytokines, chemokines, growth factors, and MMPs that can alter the local immune microenvironment. Among the immune cells involved in chronic inflammation, MDSCs are key mediators of immune suppression and tumour progression. MDSCs inhibit CD8⁺ T-cell and NK-cell activity, promote Treg expansion, and facilitate angiogenesis, EMT, tumour invasion, thereby establishing a tumour supportive microenvironment.

Oral squamous cell carcinoma (OSCC) is the most common malignancy

1. Reyes M, Urra H, Peña-Oyarzún D. Evaluating the link between periodontitis and oral squamous cell carcinoma through Wnt/β-catenin pathway: a critical review. Front Oral Health. 2025;6:1575721. [Google Scholar] [Crossref]

2. Chandra A, Singh A, Sebastian B, Agnihotri A, Bali R, Verma P. Oral squamous cell carcinomas in age distinct population: A comparison of p53 immunoexpression. J Cancer Res Ther. 2013;9(4):587. [Google Scholar] [Crossref]

3. Chang K-P, Kao H-K, Wu C-C, Fang K-H, Chang Y-L, Huang Y-C, et al. Pretreatment interleukin-6 serum levels are associated with patient survival for oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg. 2013;148(5):786–91. [Google Scholar] [Crossref]

4. Könönen E, Gursoy M, Gursoy U. Periodontitis: A multifaceted disease of tooth-supporting tissues. J Clin Med . 2019;8(8):1135 [Google Scholar] [Crossref]

5. Colonia-Garcha A, Vilez G, Duque-Duque M, De Andrade A. Possible association of periodontal disease with oral cancer and oral potentially malignant disorders: a sys tematic review. Acta Odontol Scand. 2020;78(7):553–9. [Google Scholar] [Crossref]

6. Niklander SE, Aránguiz P, Faunes F, Martínez-Flores R. Aging and oral squamous cell carcinoma development: the role of cellular senescence. Front Oral Health. 2023;4:1285276. [Google Scholar] [Crossref]

7. Coppé J-P, Desprez P-Y, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol . 2010;5(1):99–118. [Google Scholar] [Crossref]

8. Zhu W, Liang M. Periodontal ligament stem cells: Current status, concerns, and future prospects. Stem Cells In. 2015;2015:1–11. [Google Scholar] [Crossref]

9. Zhao X, Lin H, Ding T, Wang Y, Liu N, Shen Y. Overview of the main biological mechanisms linked to changes in periodontal ligament stem cells and the inflammatory microenvironment. J Zhejiang Univ Sci B. 2023;24(5):373–86. [Google Scholar] [Crossref]

10. Gabrilovich DI. Myeloid-derived suppressor cells. Cancer Immunol Res. 2017;5(1):3–8. [Google Scholar] [Crossref]

11. Babu S, Manavalan MJ, Jasmine SH, Krishnan M. Tumor microenvironment in oral squamous cell carcinoma: Implications for novel therapies. Oral Oncol Rep. 2024;12(100666):100666 [Google Scholar] [Crossref]

12. Biray Avci C, Goker Bagca B, Nikanfar M, Takanlou LS, Takanlou MS, Nourazarian A. Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications. Front Pharmacol [Internet]. 2024;15(1442888). [Google Scholar] [Crossref]

13. Obeagu EI. Inflammation, immunity, and invasion: the pivotal role of cytokine storms in cervical carcinogenesis. Ann Med Surg (Lond) . 2026;88(1):492–9 [Google Scholar] [Crossref]

14. Azzi S, Hebda JK, Gavard J. Vascular permeability and drug delivery in cancers. Front Oncol. 2013;3 [Google Scholar] [Crossref]

15. Nie F, Wang S, Tian H, Zhang J, Yin Q, Ju J, et al. Periodontitis promotes OSCC and prostate cancer progression and immunosuppression by skewing myeloid differentiation of HSPCs. J Dent Res . 2026;105(1):138–48. [Google Scholar] [Crossref]

16. Könönen E, Gursoy M, Gursoy U. Periodontitis: A multifaceted disease of tooth-supporting tissues. J Clin Med . 2019;8(8):113 [Google Scholar] [Crossref]

17. Reyes M, Urra H, Peña-Oyarzún D. Evaluating the link between periodontitis and oral squamous cell carcinoma through Wnt/β-catenin pathway: a critical review. Front Oral Health [Internet]. 2025;6:1575721 [Google Scholar] [Crossref]

18. Li R, Wang H. Re: re: Association between periodontal disease and oral squamous cell carcinoma: A systematic review and meta-analysis. Br J Oral Maxillofac Surg. 2024;62(4):384. [Google Scholar] [Crossref]

19. Groeger S, Jarzina F, Domann E, Meyle J. Porphyromonas gingivalis activates NFκB and MAPK pathways in human oral epithelial cells. BMC Immunol.2017;18(1) [Google Scholar] [Crossref]

20. Irani S, Barati I, Badiei M. Periodontitis and oral cancer - current concepts of the etiopathogenesis. Oncol Rev . 2020;14(1):465 [Google Scholar] [Crossref]

21. Han N, Liu Y, Du J, Xu J, Guo L, Liu Y. Regulation of the host immune microenvironment in periodontitis and periodontal bone remodeling. Int J Mol Sci . 2023;24(4):3158 [Google Scholar] [Crossref]

22. Bogdan-Andreescu CF, Albu Ștefan-D, Slăvescu DA, Bubulac L, Tudor V, Botoacă O, et al. Periodontitis-induced immune reprogramming: Implications for cancer immunotherapy response. Biomedicines. 2026;14(2):480 [Google Scholar] [Crossref]

23. Lin X-J, Yuan Q, Zhou J, Dong Y-L, Sunchuri D, Guo Z-L. Cellular senescence: A new perspective on the suppression of periodontitis (Review). Mol Med Rep.l..2024;30(6):238. [Google Scholar] [Crossref]

24. Zhang Z, Deng M, Hao M, Tang J. Periodontal ligament stem cells in the periodontitis niche: inseparable interactions and mechanisms. J Leukoc Biol [Internet]. 2021;110(3):565–76 [Google Scholar] [Crossref]

25. Xu Y, Zheng J, Liu M, Fu Z, Wang P. Exendin‐4 reduces senescence of inflammation‐induced periodontal ligament stem cells through SIRT1/Notch1 signaling. Stem Cells Int . 2025;2025(1) [Google Scholar] [Crossref]

26. Hu M, Liu R, Chen X, Yan S, Gao J, Zhang Y, et al. Metabolomics dysfunction in replicative senescence of periodontal ligament stem cells regulated by AMPK signaling pathway. Stem Cells Dev . 2024;33(21–22):607–15 [Google Scholar] [Crossref]

27. Yamashita A, Tenshin H, Matsuki S, Nishino G, Ser-Od S, Saito FM, et al. Inflammatory cytokines secreted from senescent periodontal ligament cells influence the osteocyte network in alveolar bone. JBMR Plus.2026;10(3). [Google Scholar] [Crossref]

28. Roato I, Baima G, Orrico C, Mosca Balma A, Alotto D, Romano F, et al. Senescent markers expressed by periodontal ligament-derived stem cells (PDLSCs) harvested from patients with periodontitis can be rejuvenated by RG108. Biomedicines. 2023;11(9):2535 [Google Scholar] [Crossref]

29. Coppé J-P, Desprez P-Y, Krtolica A, Campisi J. The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu Rev Pathol. 2010;5(1):99–118 [Google Scholar] [Crossref]

30. Chen S, Zhou D, Liu O, Chen H, Wang Y, Zhou Y. Cellular senescence and periodontitis: Mechanisms and therapeutics. Biology (Basel). 2022;11(10):1419. [Google Scholar] [Crossref]

31. Rattanaprukskul K, Xia X-J, Jiang M, Albuquerque-Souza E, Bandyopadhyay D, Sahingur SE. Molecular signatures of senescence in periodontitis: Clinical insights. J Dent Res. 2024;103(8):800–8. [Google Scholar] [Crossref]

32. Salminen A, Kauppinen A, Kaarniranta K. Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence. Biogerontology.2018;19(5):325–39. [Google Scholar] [Crossref]

33. Talarico G, Orecchioni S, Falvo P, Bertolini F. Myeloid-derived suppressor cells (MDSCs) at the crossroad of senescence and cancer. Cancers (Basel). 2025;17(13):2251. [Google Scholar] [Crossref]

34. Karin N. The development and homing of myeloid-derived suppressor cells: From a two-stage model to a multistep narrative. Front Immunol. 2020;11(557586). [Google Scholar] [Crossref]

35. Kouketsu A, Haruka S, Kuroda K, Hitoshi M, Kensuke Y, Tsuyoshi S, et al. Myeloid-derived suppressor cells and plasmacytoid dendritic cells are associated with oncogenesis of oral squamous cell carcinoma. J Oral Pathol Med. 2023;52(1):9–19. [Google Scholar] [Crossref]

36. Valero-Monroy O, Garcia-Cervantes G, Marquez-Corrales LF, Leija-Montoya AG, Sandoval-Basilio J, Martinez-Coronilla G, et al. Myeloid derived suppressor cell: A new player in periodontal disease? Med Hypotheses . 2016;95:35–8. [Google Scholar] [Crossref]

37. Imatani T, Kato T, Okuda K. Production of inflammatory cytokines by human gingival fibroblasts stimulated by cell‐surface preparations of Porphyromonas gingivalis. Oral Microbiol Immunol. 2001;16(2):65–72. [Google Scholar] [Crossref]

38. Ambili R, Janam P, Babu PS, Prasad M, Vinod D, Kumar PA, et al. Differential expression of transcription factors NF-κB and STAT3 in periodontal ligament fibroblasts and gingiva of healthy and diseased individuals. Archives of oral biology. 2017;82:19–26. [Google Scholar] [Crossref]

39. Ali A, Molska GR, Yeo H, Esfandiari N, Jeong W, Huang M, et al. Immune microenvironment in Oral Potentially Malignant Disorders and oral cancer: A narrative review. Int J Mol Sci . 2025;26(14):6650 [Google Scholar] [Crossref]

40. Pang X, Fan H-Y, Tang Y-L, Wang S-S, Cao M-X, Wang H-F, et al. Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma. PLoS One. 2020;15(2):e0229089. [Google Scholar] [Crossref]

41. Weber R, Groth C, Lasser S, Arkhypov I, Petrova V, Altevogt P, et al. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cell Immunol.2021;359(104254):104254 [Google Scholar] [Crossref]

42. Liu Q, Yu S, Li A, Xu H, Han X, Wu K. Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment. Tumour Biol. 2017;39(6):1010428317712445 [Google Scholar] [Crossref]

43. Bronte V, Brandau S, Chen S-H, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7(1):12150. [Google Scholar] [Crossref]

44. Yang Y, Li C, Liu T, Dai X, Bazhin AV. Myeloid-derived suppressor cells in tumors: From mechanisms to antigen specificity and microenvironmental regulation. Front Immunol. 2020;11:1371 [Google Scholar] [Crossref]

• Quantitative Assessment of Serum C - Reactive Protein Levels among Smokers and Non Smokers
• Extraction and Characterization of Eco-Friendly Hair Dye from Agricultural Waste: A Study on Coconut Husk
• Intermittent Preventive Treatment among Pregnant Women Attending a Tertiary Healthcare Facility in Jos, North Central Nigeria: Adherence Patterns and Preliminary Assessment of Associated Factors
• Assessment Of Degradative Potentials Of Bacteria Isolated From Palm Oil-Polluted Site Using Spectrophotometric Method
• An Analysis of Machine and Deep Learning Insights on the Use of Artificial Intelligence in Oral and Maxillofacial Pathology